Related Experiment Video

Updated: Jun 17, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Clinical differences between early-onset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6

Simone Sep1, Jef Verbeek, Gerardus Koek

  • 1Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands. simone.sep@og.unimaas.nl

American Journal of Obstetrics and Gynecology
|December 22, 2009
PubMed

Insights

Women with HELLP syndrome had fewer metabolic syndrome abnormalities and lower thrombophilia risk compared to preeclampsia patients. This study differentiates long-term health outcomes for these conditions.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Cardiovascular and Metabolic Health

Background:

  • HELLP syndrome and preeclampsia (PE) are severe hypertensive disorders of pregnancy.
  • Understanding long-term sequelae is crucial for patient management.
  • Differences in postpartum metabolic and hemostatic profiles remain incompletely defined.

Purpose of the Study:

  • To investigate clinical and laboratory variable differences between former patients with HELLP syndrome and those with PE without HELLP.
  • To compare postpartum metabolic, hemodynamic, and hemostatic status in these patient groups.

Main Methods:

  • A comparative study involving early-onset HELLP (n=75) and early-onset PE (n=40) cohorts.
  • Assessment of clinical features during the hypertensive complication.
  • Evaluation of metabolic, hemodynamic, and hemostatic variables at least 6 months postpartum.

Main Results:

  • HELLP patients showed a borderline higher frequency of eclampsia (13% vs 3%).
  • Postpartum, HELLP patients had lower prevalence of hypertension (19% vs 33%), proteinuria (2% vs 23%), thrombophilia (6% vs 27%), obesity (9% vs 33%), hypertriglyceridemia (1% vs 15%), hyperglycemia (0% vs 11%), and elevated homocysteine (6% vs 21%).

Conclusions:

  • Women with HELLP syndrome exhibited fewer abnormalities consistent with metabolic syndrome compared to PE patients.
  • A significantly lower prevalence of thrombophilia was observed in women with a history of HELLP syndrome.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...